The importance of great leadership amidst the meteoric rise of India’s growth should always be the first priority. As an editorial, we make sure that our words do the proper courtesy of gracing the resilience that goes into succeeding in entrepreneurship. It’s not only the sheer hard work and perseverance that seals the deal to be a great business leader, but also the strategic decision that dictates composure and planning behind making a product/business successful. This piece is a direct alignment to that vision and positioning Akshay Gosavi, founder of Sterilem Biosystems, to be a pioneer in the biopharmaceutical and life sciences industry.
Studying the background of Akshay Gosavi:
Behind Akshay Gosavi’s journey stands his father, Mr. Vishnu Gosavi, whose entire life was dedicated to giving his children, Akshay and Gayatri, opportunities for a better future. As the sole breadwinner of the family, he worked tirelessly, taking day and night shifts and later working part-time as an agriculture consultant to support his family and provide his children with the best possible education. He sold his land and made countless personal sacrifices, always placing his children’s needs before his own. He never allowed financial limitations to become a barrier to their education or ambitions. For him, his children’s dreams were always more important than his own comforts, and he quietly worked behind the scenes to give them the foundation on which they could build their lives.
When Akshay decided to leave his job in 2019 and build Sterilem, his father once again stood firmly behind his son at a time when there was no certainty of success. He contributed the wealth he had accumulated through years of hard work and, when the company needed further financial support, went as far as selling his house and other personal assets to help Akshay continue his dream. His mother, Mrs. Mandarani Gosavi, also stood beside him during these difficult years and sold her jewelry to support the company. For Akshay, these sacrifices are worth far more than their monetary value—they represent his parents’ unconditional trust, love, and belief in him. His father did not simply help fund his son’s education or business; he invested a lifetime of hard work, sacrifice, and faith into his children’s future. Much of what Akshay has been able to build today stands on the sacrifices his parents made when there was no guarantee that their investment would ever return.
Scaling Sterilem Biosystems with Akshay’s Strategic Decision-Making:
With no influential connection or industry network, Akshay still navigated the biotechnology space in his career and learned from experts. His firsthand experience came from working at companies like Serum Institute of India Pvt. Ltd. in Downstream Processing – Vaccines and Biologics, Wockhardt Ltd., YMC India Pvt. Ltd., and Nano Micro Tech India. Akshay Gosavi also enriched his academic prowess by getting associated with IIT Bombay on enzyme process optimization projects. Furthermore, academically, Akshay also pursued an integrated B.Tech. + M.Tech. in Biotechnology from the D. Y. Patil University, School of Biotechnology and Bioinformatics, Navi Mumbai.
Akshay Gosavi leveraged his years of experience in the sector into understanding the gap and building products. His creation, Sterilem Biosystems, is the culmination of years of strategic decision-making compiled into an operational model that runs on modern industry demands.
Akshay Gosavi: “The focus is on expanding single-use and fluid-management solutions, strengthening technical capabilities, developing customized solutions, and supporting customers through the complete requirement-to-solution journey.”
In 2019, Akshay started his company with a humble beginning with genomics services and subsequently expanded into proteomics. He recalls the early days when his company received a “relatively small order of approximately ₹10,000 for the year.” Eventually, Sterile Biosystems picked up fast and scaled beyond genomics and proteomics into the broader bioprocess and life sciences ecosystem. The business trajectory of Sterilem Biosystems under Akshay Gosavi’s leadership has seen it all. Akshay takes us down the memory where his hours behind the ecosystem did all the taking. He kept Sterilem as his priority, as he understands the slogging that goes behind building a startup. There are no hours, no shying away from hustle, and no second thoughts rather than building the best possible product in the niche.
Key takeaways from Akshay Gosavi’s piece:
The company’s future is about strengthening the goal to provide end-to-end bioprocess solutions. Akshay Gosavi told Business Outreach that in 2025, Sterilem entered into a strategic partnership with Accumax, “creating an opportunity to strengthen its capabilities and expand its presence within the bioprocess and life sciences ecosystem.”
In the next 10 years, Akshay Gosavi’s foresight will take Sterilem to become one of the strongest and most research-driven organizations in the bioprocess industry. Sterilem is envisioning itself to be the industry leader in areas like single-use technologies, fluid management, mixing solutions, filtration, customized assemblies, process solutions, manufacturing, R&D, technical development, quality and validation support, and strategic technology partnerships.
Akshay says, “Sterilem is not the story of one person. It is the story of every person who believed in the vision, worked relentlessly, stood beside us during difficult times, and contributed something to this journey. I will always be grateful to every individual who has been a
part of Sterilem. Whatever we have achieved has been possible because of the people.
who gave their time, their energy, and their belief to this organization.”
